Democratic Gov. Andy Beshear said that the establishment of the center should not slow down legislative efforts to legalize medical cannabis access.
Topic: Marijuana Research
Browse these news releases for articles that indicate laws or changes on how marijuana research is conducted. For articles about specific topics of “Research Studies” please choose that topic.
Researchers concluded, “Placements due to physical abuse, parental neglect, and parental incarceration decrease after legalization, providing evidence that legalization reduces substantive threats to child welfare.”
For decades, scientists have complained that federally provided cannabis is of inferior quality and that it is not representative of the products available in state-legal markets.
Under current regulations, the DEA is primarily tasked with licensing marijuana cultivators, as well as granting Schedule I licenses to scientists wishing to study cannabis in clinical settings.
“Minor cannabinoids and their chemical homologs offer the potential medicinal benefits of Δ9-THC without adverse effects,” the study’s authors concluded.
Investigators concluded, “Our results clearly demonstrate that NIDA cannabis samples are substantially genetically different from most commercially available drug-type strains.”
Investigators concluded, “The ‘sativa–indica’ scale currently used to label cannabis poorly captures overall genomic and metabolomic variation.”
Since 1968, only the University of Mississippi has been federally licensed to engage in the growing of cannabis for FDA-approved clinical research.